New fitting tech simplifies Bausch + Lomb ULTRA contact lenses for digital eyes
16.06.2026 - 08:42:11 | ad-hoc-news.deEdited by ad hoc news New Releases & Launches Desk. Reviewed before publication on 06/16/2026 at 6:41 AM ET. Details in the imprint.
Bausch + Lomb is leaning into the strain of screen-heavy routines with its ULTRA family of soft contact lenses, a silicone hydrogel line positioned for US wearers who spend long hours on digital devices and want more comfortable monthly lenses without jumping to premium daily disposables. The range spans sphere, multifocal and astigmatism designs, giving eye-care professionals a single material platform they can fit across a wide spectrum of prescriptions rather than switching between unrelated lens families for different vision needs.
What Bausch + Lomb ULTRA brings to digital device users and ECPs
At the core of the ULTRA portfolio is Bausch + Lomb’s silicone hydrogel material with the company’s MoistureSeal technology, which the manufacturer says helps maintain nearly 95% of lens moisture for 16 hours to address contact lens dryness associated with reduced blinking during digital device use. The official product page describes ULTRA lenses as monthly replacements with a high oxygen-transmissible silicone hydrogel design and a low modulus for comfort, with sphere options for myopia and hyperopia, ULTRA for Astigmatism for toric wearers and ULTRA for Presbyopia and ULTRA Multifocal for Astigmatism for patients who need multifocal correction.
For US practices, one practical angle is that the ULTRA line is built around a consistent fitting philosophy, including toric and multifocal designs that share similar handling and on-eye behavior, which can help shorten chair time when moving an existing ULTRA wearer into a more complex design such as multifocal toric. Independent trade coverage notes that Bausch + Lomb has positioned ULTRA specifically as a lens family for digital device users and highlighted MoistureSeal’s performance in clinical work, with reported comfort benefits in patients who spend significant portions of the day on screens compared with older hydrogel lenses. An article in Review of Contact Lenses outlines how the ULTRA family was introduced and subsequently expanded into astigmatism and presbyopia segments, emphasizing its role for screen-centric wearers, and many US optometrists now keep the range as part of their standard monthly lens offering alongside daily disposable alternatives for patients prioritizing convenience over replacement cost.
The ULTRA platform also gives Bausch + Lomb a foundation for incremental launches and practice tools, such as online fitting calculators and chairside materials that tie the various ULTRA sub-lines together rather than marketing them as disparate SKUs, which can simplify staff training and patient communication about upgrades from sphere to multifocal or toric designs. In its investor communications, the company has highlighted contact lenses and lens care as a core growth engine within its Vision Care segment in North America and globally, and ULTRA, together with daily disposable offerings, sits at the center of that strategy as Bausch + Lomb tries to capture both entry-level and premium contact lens users who are frustrated with dryness or inconsistent vision in competing monthly products. In a recent investor update the company pointed to double-digit Vision Care growth and specifically cited its ULTRA and daily disposable franchises as key contributors, underscoring why refining the ULTRA platform for digital device users and broad prescription coverage remains commercially important.
Bausch + Lomb presents the ULTRA family as a bridge between traditional hydrogels and higher-priced daily disposable silicone hydrogels, targeting value-conscious monthly wearers who still want modern material properties and an explicit focus on screen-related comfort; the company’s ability to keep those patients within the ULTRA ecosystem as their prescriptions evolve is central to its recurring revenue model in contact lenses. Shares of Bausch + Lomb Corporation (CA07174N1090) trade on the New York Stock Exchange in US dollars, and the company regularly frames its ULTRA line as a strategic pillar in driving Vision Care revenue in its quarterly filings and presentations for investors watching the balance between surgical, pharmaceutical and consumer eye-health sales.
Bausch + Lomb ULTRA lenses in brief
- Product: Bausch + Lomb ULTRA contact lenses
- Manufacturer: Bausch + Lomb Corporation
- Category: New Release / Monthly soft contact lenses
- Launch date: Initial ULTRA sphere launch 2014, with later extensions into astigmatism and presbyopia
- MSRP / Price: Varies by channel; typically sold via US eye-care practices and optical retailers as monthly lenses with per-box pricing
- Availability: Widely available in the US through optometrists, ophthalmology clinics and optical chains, as well as authorized online contact lens retailers
- Target audience: Contact lens wearers who use digital devices extensively and prefer monthly replacement lenses, including those with astigmatism or presbyopia
- Key differentiator / USP: Silicone hydrogel material with MoistureSeal technology positioned to maintain moisture and comfort for long hours of digital device use across a unified family of sphere, toric and multifocal designs
More background on Bausch + Lomb
Further coverage on the manufacturer’s product pipeline, including contact lenses and surgical devices, is available via our stock and company topic page and the company’s own investor communications.
More Bausch + Lomb coverage Investor RelationsThis article was a.i.-assisted and editorially reviewed. Product information without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Trading involves risk up to and including the total loss of invested capital.
